Literature DB >> 29338309

Oral microbiota reduce wound healing capacity of epithelial monolayers, irrespective of the presence of 5-fluorouracil.

Eline Vanlancker1, Barbara Vanhoecke1, Tom Sieprath2,3, Janie Bourgeois1, Annelore Beterams1, Barbara De Moerloose4, Winnok H De Vos2,3, Tom Van de Wiele1.   

Abstract

Oral mucositis is still one of the most painful side effects of chemotherapeutic treatment and a mounting body of evidence suggests a key role for the oral microbiome in mucositis development. However, the underlying mechanisms remain elusive. In this work, we have investigated the interactions between the host, the microbiome, and chemotherapeutic treatments in more detail. The effect of 5-fluorouracil, commonly inducing mucositis, was assessed on a co-culture model that consists of an epithelial cell layer and a biofilm derived from oral microbiota from different types of samples (saliva, buccal swabs and tongue swabs) and donors (healthy individuals and patients suffering from mucositis). After 24 h co-incubation, all oral microbial samples were found to reduce wound healing capacity with 26 ± 15% as compared with untreated condition. Compared with saliva and tongue samples, buccal samples were characterized by lower bacterial cell counts and hence higher wound healing capacity. For samples from healthy individuals, an inverse correlation was observed between bacterial cell counts and wound healing capacity, whereas for patients suffering from mucositis no correlation was observed. Moreover, patient-derived samples had a less diverse microbial community and higher abundances of pathogenic genera. No major impact of 5-fluorouracil on wound healing capacity or the composition of the microbiome was seen at physiologically relevant concentrations in the mouth. In conclusion, bacterial cell count is inversely correlated with wound healing capacity, which emphasizes the importance of oral hygiene during oral wound healing in healthy individuals. However, future research on extra measures besides oral hygiene is needed to assure a good wound healing during mucositis, as for patients the bacterial composition seems also crucial. The direct effect of 5-fluorouracil on both the microbiome and wound healing is minimal, pointing to the importance of the host and its immune system in chemotherapy-induced microbial shifts. Impact statement Chemotherapy-induced oral mucositis has a major impact on the quality of life of patients. The additional costs and treatment time associated with this pathology are significant. Although the pathology of the disease is well understood, the role and importance of oral microbiota currently are less clear. In this study, we focused on the effect of oral microbiota on wound healing, the final phase of oral mucositis, during 5-FU exposure. We show that the bacterial load and composition have a major impact on the healing process in contrast to 5-FU which only marginally slows down healing. This emphasizes the importance of good oral health care during oral mucositis to minimize bacterial load around the oral lesions. However, since we show that also the composition of the oral microbiome plays a role in wound recovery, the identification of specific pathogenic species or their metabolites might be worthwhile to allow proper treatment.

Entities:  

Keywords:  Bacteria; chemotherapy; host–microbe interactions; in vitro model; microbiome; oral mucositis

Mesh:

Substances:

Year:  2018        PMID: 29338309      PMCID: PMC6022929          DOI: 10.1177/1535370217753842

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  38 in total

Review 1.  Oral microbial communities: biofilms, interactions, and genetic systems.

Authors:  P E Kolenbrander
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

Review 2.  Bacteria and wound healing.

Authors:  Ruth Edwards; Keith G Harding
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

3.  Distribution of bacterioplankton in meromictic Lake Saelenvannet, as determined by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA.

Authors:  L Ovreås; L Forney; F L Daae; V Torsvik
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

4.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

Review 5.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Authors:  Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-06       Impact factor: 3.603

6.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

Review 7.  Mucositis: pathobiology and management.

Authors:  Alessandro Villa; Stephen T Sonis
Journal:  Curr Opin Oncol       Date:  2015-05       Impact factor: 3.645

8.  Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples.

Authors:  Nicola Segata; Susan Kinder Haake; Peter Mannon; Katherine P Lemon; Levi Waldron; Dirk Gevers; Curtis Huttenhower; Jacques Izard
Journal:  Genome Biol       Date:  2012-06-14       Impact factor: 13.583

9.  Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.

Authors:  Alexa M G A Laheij; Johannes J de Soet; Peter A von dem Borne; Ed J Kuijper; Eefje A Kraneveld; Cor van Loveren; Judith E Raber-Durlacher
Journal:  Support Care Cancer       Date:  2012-04-26       Impact factor: 3.603

10.  The influence of oral bacteria on epithelial cell migration in vitro.

Authors:  Alexa M G A Laheij; Johannes J de Soet; Enno C I Veerman; Jan G M Bolscher; Cor van Loveren
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

View more
  5 in total

1.  Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  Roni Shouval; Adi Eshel; Bar Dubovski; Amir A Kuperman; Ivetta Danylesko; Joshua A Fein; Shalev Fried; Mika Geva; Elizaveta Kouniavski; Hadar Neuman; Ayelet Armon-Omer; Radi Shahien; Efrat Muller; Cecilia Noecker; Elhanan Borenstein; Yoram Louzoun; Arnon Nagler; Omry Koren
Journal:  Blood Adv       Date:  2020-07-14

Review 2.  Roles of Toll-Like Receptors in Radiotherapy- and Chemotherapy-Induced Oral Mucositis: A Concise Review.

Authors:  Ling Ji; Siyuan Hao; Jiantao Wang; Jing Zou; Yan Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

Review 3.  Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis.

Authors:  Ghanyah Al-Qadami; Ysabella Van Sebille; Joanne Bowen; Hannah Wardill
Journal:  Front Oral Health       Date:  2022-03-28

4.  The incidence of severe oral mucositis and its occurrence sites in pediatric oncologic patients.

Authors:  J-R Guimarães; L-G Carvalho; L-C Damascena; M-E Sampaio; I-L Ribeiro; S-A Sousa; A-M Valença
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-05-01

Review 5.  Armed to the Teeth-The Oral Mucosa Immunity System and Microbiota.

Authors:  Maja Ptasiewicz; Ewelina Grywalska; Paulina Mertowska; Izabela Korona-Głowniak; Agata Poniewierska-Baran; Paulina Niedźwiedzka-Rystwej; Renata Chałas
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.